Alterna Wealth Management, Inc Caladrius Biosciences, Inc. Transaction History

Alterna Wealth Management, Inc

  • $108 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.41 - $0.74 $1,312 - $2,368
-3,200 Reduced 24.24%
10,000 $5,000
Q1 2022

May 12, 2022
SELL
$0.63 - $1.03 $37,674 - $61,594
-59,800 Reduced 81.92%
13,200 $10,000
Q4 2021

Feb 10, 2022
BUY
$0.83 - $1.22 $60,590 - $89,060
73,000 New
73,000 $61,000

About CALADRIUS BIOSCIENCES, INC.

CLBS Quotes by TradingView
  • Ticker CLBS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,583,200
  • Market Cap $25.8M
  • Description
  • Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...
More about CLBS
Track This Portfolio

Track Alterna Wealth Management, Inc Portfolio

Follow Alterna Wealth Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alterna Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alterna Wealth Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email